Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (+)-(2s)-2-((s)-(2-ethoxyphenoxy)phenylmethyl)morpholine
1. (s,s)-reboxetine
2. 98819-76-2
3. S,s-reboxetine
4. (2s)-2-[(s)-(2-ethoxyphenoxy)-phenylmethyl]morpholine
5. L8s50zy490
6. (2s)-2-[(s)-2-ethoxyphenoxy(phenyl)methyl]morpholine
7. (s)-2-((s)-(2-ethoxyphenoxy)(phenyl)methyl)morpholine
8. (+)-(2s)-2-((s)-(2-ethoxyphenoxy)phenylmethyl)morpholine
9. Morpholine, 2-((s)-(2-ethoxyphenoxy)phenylmethyl)-, (2s)-
10. Esreboxetine [usan]
11. Esreboxetine (usan/inn)
12. Esreboxetine [usan:inn]
13. Unii-l8s50zy490
14. S-reboxetine
15. Pnu 165442g
16. Tocris-1982
17. Ncgc00025335-01
18. Esreboxetine [inn]
19. (s,s)-(+)-reboxetine
20. Schembl34534
21. Esreboxetine [who-dd]
22. Chembl180101
23. Gtpl4808
24. Zinc6923
25. Bdbm35226
26. (2s)-2-[(s)-(2-ethoxyphenoxy)-phenyl-methyl]morpholine
27. Chebi:125535
28. Dtxsid601009938
29. Db12395
30. D09340
31. 819s762
32. Q5399299
33. Brd-k32814891-001-01-1
Molecular Weight | 313.4 g/mol |
---|---|
Molecular Formula | C19H23NO3 |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 313.16779360 g/mol |
Monoisotopic Mass | 313.16779360 g/mol |
Topological Polar Surface Area | 39.7 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 333 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Reboxetine has known human metabolites that include O-desethylreboxetine, Phenol A, and Phenol B.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Regulatory Info :
Registration Country : Australia
Brand Name : Edronax
Dosage Form : tablet
Dosage Strength : 4 mg
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Edronax
Dosage Form : tablet
Dosage Strength : 4 mg
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Edronax 4 mg
Dosage Form : TAB
Dosage Strength : 4mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Global Sales Information
Market Place
ABOUT THIS PAGE
55
PharmaCompass offers a list of Reboxetine Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Reboxetine Mesylate manufacturer or Reboxetine Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Reboxetine Mesylate manufacturer or Reboxetine Mesylate supplier.
PharmaCompass also assists you with knowing the Reboxetine Mesylate API Price utilized in the formulation of products. Reboxetine Mesylate API Price is not always fixed or binding as the Reboxetine Mesylate Price is obtained through a variety of data sources. The Reboxetine Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Solvex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Solvex, including repackagers and relabelers. The FDA regulates Solvex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Solvex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Solvex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Solvex supplier is an individual or a company that provides Solvex active pharmaceutical ingredient (API) or Solvex finished formulations upon request. The Solvex suppliers may include Solvex API manufacturers, exporters, distributors and traders.
click here to find a list of Solvex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Solvex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Solvex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Solvex GMP manufacturer or Solvex GMP API supplier for your needs.
A Solvex CoA (Certificate of Analysis) is a formal document that attests to Solvex's compliance with Solvex specifications and serves as a tool for batch-level quality control.
Solvex CoA mostly includes findings from lab analyses of a specific batch. For each Solvex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Solvex may be tested according to a variety of international standards, such as European Pharmacopoeia (Solvex EP), Solvex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Solvex USP).